Log In
Print
BCIQ
Print
Print this Print this
 

tavaborole (AN2690)

  Manage Alerts
Collapse Summary General Information
Company Anacor Pharmaceuticals Inc.
DescriptionTopical antifungal agent
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationOnychomycosis
Indication DetailsTreat onychomycosis
Regulatory Designation

U.S. - Special Protocol Assessment (Treat onychomycosis);
U.S. - Undisclosed Review (Treat onychomycosis)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today